Package Leaflet: Information for the User
Betahistina Tarbis 16 mg tablets EFG
Betahistina dihydrochloride
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Betahistina Tarbis contains betahistina. This medication is referred to as a "histamine analogue".
Betahistina is indicated for the treatment of vertigo, tinnitus, and hearing loss associated with Meniere's syndrome.
This medication works by improving blood flow in the inner ear. This reduces the accumulation of pressure.
Do not take Betahistina Tarbis
If you are in any of the above situations, do not take this medication and consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take betahistina:
If any of the above applies to you, consult your doctor or pharmacist before starting to take betahistina.
Your doctor will tell you if it is safe for you to start taking this medication.
It is also possible that your doctor may want to monitor your asthma while you are taking betahistina.
Other medications and Betahistina Tarbis
Tell your doctor or pharmacist if you are using, have recently used, or may need to use other medications, including those obtained without a prescription. This includes herbal medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medications:
Using Betahistina Tarbis with food, drinks, and alcohol
You can take this medication with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Do not take betahistina tablets if you are pregnant unless your doctor decides it is absolutely necessary. Ask your doctor for advice.
Do not breastfeed while taking betahistina tablets unless your doctor tells you to. It is not known if betahistina passes into breast milk.
Driving and using machines
Betahistina is unlikely to affect your ability to drive or use machines or tools.
However, remember that the condition for which you are being treated with betahistina (vertigo, tinnitus, and hearing loss associated with Meniere's syndrome) may make you feel dizzy or sick, affecting your ability to drive and use machines.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How to take Betahistina Tarbis
How much Betahistina Tarbis to take
Always follow your doctor's instructions, as your doctor may adjust your dose.
Initially, 8 to 16 mg three times a day, preferably with meals.
Maintenance doses are generally in the range of 24 to 48 mg per day.
Continue taking your tablets. They may take some time to start working.
Betahistina is not recommended for children under 18 years of age.
If you stop treatment with Betahistina Tarbis
Continue taking the tablets until your doctor tells you to stop.
Even when you start to feel better, your doctor may want you to continue taking the tablets for some time to ensure that the medication has worked completely.
If you take more Betahistina Tarbis than you should
If you or someone else takes too much betahistina (overdose), talk to a doctor or go to a hospital immediately. Take the medication with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service (telephone 91 562 04 20), indicating the medication and the amount ingested.
If you forget to take Betahistina Tarbis
If you forget to take a dose, wait until the next one. Do not try to make up for the missed dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
The following serious side effects may occur during treatment with Betahistina Tarbis:
Allergic reactions such as:
If you experience any of these side effects, stop treatment immediately and talk to your doctor.
Common(may affect up to 1 in 10 patients):
Other side effects that have been reported with the use of betahistina
Itching, skin rash, hives, mild stomach upset such as vomiting, stomach pain, and swelling. Taking betahistina with food may help reduce stomach problems.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date stated on the blister pack and carton after "EXP". The expiration date is the last day of the month indicated.
Medications should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Betahistina Tarbis
The active ingredient is betahistina dihydrochloride.
Each tablet contains 16 mg betahistina dihydrochloride, equivalent to 10.42 mg betahistina.
.
The other ingredients are:
Microcrystalline cellulose (E460), mannitol (E421), colloidal anhydrous silica (E551), citric acid (E330), talc (E553b).
Appearance and packaging of the product
Tablet.
Betahistina Tarbis 16 mg tablets EFG
White to off-white, scored, round, biconvex tablets, engraved with "16 / B" on one side and smooth on the other (diameter 8.5 mm and thickness 4.20 mm).
The tablet can be divided into equal doses.
Betahistina Tarbis tablets are available in blister packs of 30, 60, 84, 90, and 120 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Tarbis Farma S.L.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Manufacturer
Amarox Pharma B.V.
Rouboslaan 32
Voorschoten, 2252TR
Netherlands
This medication is authorized in the Member States of the European Economic Area under the following names:
Netherlands: Betahistine Amarox 16 mg tablets
Spain: Betahistina Tarbis 16 mg tablets EFG
Date of the last revision of this package leaflet: January 2022
Detailed and up-to-date information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of BETAHISTINE TARBIS 16 mg TABLETS in October, 2025 is around 2.73 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.